Research and development expense [negated] Selling, general and administrative expense [negated] Tax expense (income) [negated] Deferred tax expense (income) [negated] Adjustments for depreciation and amortisation expense [negated] Increase (decrease) in working capital [total] Adjustments for decrease (increase) in inventories [negated] Adjustments for decrease (increase) in trade accounts receivable [negated] Adjustments for increase (decrease) in trade accounts payable [negated] Cash flows from (used in) operating activities [total] Purchase of property, plant and equipment, classified as investing activities [negated] Purchase of intangible assets, classified as investing activities [negated] Payments for development project expenditure [negated] Cash flows from (used in) investing activities [total] Dividends paid to equity holders of parent, classified as financing activities [negated] Dividends paid to non-controlling interests, classified as financing activities [negated] Repayments of borrowings, classified as financing activities [negated] Payments of lease liabilities, classified as financing activities [negated] Cash flows from (used in) financing activities [total] Increase (decrease) in cash and cash equivalents [total] Operating Income (before amortization of acquired intangible assets) Operating Income (before amortization of acquired intangible assets) [total] Amortisation of intangible assets acquired in business combinations Amortisation of intangible assets acquired in business combinations [negated] Operating income (after amortisation of acquired intangible assets) Operating income (after amortisation of acquired intangible assets) [total] Other non recurring operating income Other non recurring operating expenses Other non recurring operating expenses [negated] Income from loans, cash investments and marketable securities Net income (loss) of fully consolidated companies Net income (loss) of fully consolidated companies [total] Other comprehensive income from discontinued operations Other operating receivables Retained earnings and valuation adjustments reserve excluding net income (loss) for the year and the translation adjustments reserve Portion of retained earnings relating to the results for the year Accrued taxes and payroll costs o/w depreciations and amortizations of R&D assets o/w depreciations and amortizations of R&D assets [negated] o/w other amortizations o/w other amortizations [negated] Ebitda Ebitda [total] Paid restructuring Paid finance costs net of income Other non recurring operating income and expenses paid o/w R&D inventories increase o/w R&D inventories increase [negated] o/w R&D inventories decrease Change in other operating receivables and payables Change in other operating receivables and payables [negated] Change in other receivables and payables (excl. Tax) Acquisitions/Sales of investments and business (net of cash and cash equivalents) Acquisitions/Sales of investments and business (net of cash and cash equivalents) [negated] Change in investments related receivables and payables Cash provided (used) by operating and investing activities Cash provided (used) by operating and investing activities [total] Changes in cash and cash equivalents Cash and cash equivalent restated of ifrs5 After ias19 adjustment cumulative effect at date of initial application member Changes in equity